A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
Clinical trial NCT07477704 · RECRUITING
Trial details
- NCT number
- NCT07477704
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-17
- Primary completion
- 2026-12-29
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.